{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:52:33Z","timestamp":1773042753485,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T00:00:00Z","timestamp":1301270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Sickle cell disease (SCD) frequently affects the liver; if acute liver failure (ALF) develops, the only potentially effective therapeutic option is liver transplantation (LT). Only 12 patients for whom LT was performed for SCD-related ALF have been described so far. We report a retrospective series of 6 adult patients with SCD (3 men and 3 women, median age = 40.1 years) who underwent emergency LT. The indication for LT was ALF complicating cirrhosis in 5 patients (hepatitis C\/iron overload-induced cirrhosis in 3 and iron overload-induced cirrhosis in 2); one patient had autoimmune hepatitis. The median follow-up was 52.7 months (0.5-123 months). The 1-, 3-, 5-, and 10-year survival rates were 83.3%, 66.7%, 44.4%, and 44.4%, respectively. One patient died of hepatocellular failure precipitated by hyperacute allograft rejection on post-LT day 10. Soon after LT, 2 patients developed seizures; in 1 case, the seizures were a complication of early calcineurin inhibitor-induced leukoencephalopathy. Four long-term survivors benefited from specific management of SCD; specifically, the hemoglobin S fraction was maintained below 30% and the total hemoglobin level was maintained between 8 and 10 g\/dL. Two patients had mild vaso-occlusive crises. Three patients experienced a recurrence of hepatitis C virus (HCV) infection; 2 of these patients experienced reversible neurological complications while they were receiving antiviral treatment. Carefully selected patients with SCD may benefit from emergency LT. However, such patients seem to be particularly susceptible to neurological complications after LT. In contrast, severe SCD-related crises do not seem to recur if specific management is provided. Outcomes may be improved if the neurological complications can be minimized; for example, the administration of a calcineurin inhibitor can be delayed, and the management of HCV infection recurrence can be improved. <jats:bold>\n                                    Liver Transpl, 2011. \u00a9 2011 AASLD.\n                                 <\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22257","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T16:32:23Z","timestamp":1295022743000},"page":"381-392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":40,"title":["Transplantation for liver failure in patients with sickle cell disease"],"prefix":"10.1097","volume":"17","author":[{"given":"Monika","family":"Hurtova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Bachir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie Serge","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cherqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Galact\u00e9ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-5-20250124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of phenotypic manifestations of sickle cell disease.","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"R3-5-20250124","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.84.3.500","article-title":"Mortality in children and adolescents with sickle cell disease.","volume":"84","author":"Leikin","year":"1989","journal-title":"Pediatrics"},{"key":"R4-5-20250124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.thj.6200147","article-title":"Patterns of mortality in sickle cell disease in adults in France and England.","volume":"3","author":"Perronne","year":"2002","journal-title":"Hematol J"},{"key":"R5-5-20250124","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2008.09.052","article-title":"Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002.","volume":"154","author":"Yanni","year":"2009","journal-title":"J Pediatr"},{"key":"R6-5-20250124","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-198509000-00007","article-title":"Liver involvement in sickle cell disease.","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine"},{"key":"R7-5-20250124","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/jhep.2001.24114","article-title":"Sickle cell hepatopathy.","volume":"33","author":"Banerjee","year":"2001","journal-title":"Hepatology"},{"key":"R8-5-20250124","first-page":"2048","article-title":"Sickle cell intrahepatic cholestasis: approach to a difficult problem.","volume":"90","author":"Shao","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R9-5-20250124","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/0016-5085(86)90276-3","article-title":"Hepatobilary system in sickle cell disease.","volume":"90","author":"Schubert","year":"1986","journal-title":"Gastroenterology"},{"key":"R10-5-20250124","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pbc.20317","article-title":"Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients.","volume":"45","author":"Ahn","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R11-5-20250124","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/01.tp.0000184446.52454.69","article-title":"Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis.","volume":"80","author":"Baichi","year":"2005","journal-title":"Transplantation"},{"key":"R12-5-20250124","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-200002270-00036","article-title":"Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis.","volume":"69","author":"Emre","year":"2000","journal-title":"Transplantation"},{"key":"R13-5-20250124","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/00007890-200209270-00030","article-title":"Liver transplantation in a patient with S(beta)o-thalassemia.","volume":"74","author":"Gilli","year":"2002","journal-title":"Transplantation"},{"key":"R14-5-20250124","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00007890-199510150-00026","article-title":"Liver transplantation in a patient with sickle cell anemia.","volume":"60","author":"Kindscher","year":"1995","journal-title":"Transplantation"},{"key":"R15-5-20250124","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/00007890-199505270-00025","article-title":"Liver transplantation in a child with sickle cell anemia.","volume":"59","author":"Lang","year":"1995","journal-title":"Transplantation"},{"key":"R16-5-20250124","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1432-2277.2003.tb00326.x","article-title":"Successful liver transplantation in a patient with sickle-cell anaemia.","volume":"16","author":"van den Hazel","year":"2003","journal-title":"Transpl Int"},{"key":"R17-5-20250124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00007890-199901150-00010","article-title":"Hepatic sickling: an unusual cause of liver allograft dysfunction.","volume":"67","author":"Lerut","year":"1999","journal-title":"Transplantation"},{"key":"R18-5-20250124","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00007890-200202270-00022","article-title":"Combined liver and kidney transplantation in a patient with sickle cell disease.","volume":"73","author":"Ross","year":"2002","journal-title":"Transplantation"},{"key":"R19-5-20250124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/lt.20999","article-title":"Liver transplantation in children with sickle cell disease.","volume":"13","author":"Mekeel","year":"2007","journal-title":"Liver Transpl"},{"key":"R20-5-20250124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/lt.21031","article-title":"Liver transplantation for sickle cell hepatopathy.","volume":"13","author":"Friedman","year":"2007","journal-title":"Liver Transpl"},{"key":"R21-5-20250124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2008-1040593","article-title":"Fulminant and subfulminant liver failure: definitions and causes.","volume":"6","author":"Bernuau","year":"1986","journal-title":"Semin Liver Dis"},{"key":"R22-5-20250124","first-page":"46","article-title":"Vascular lesions of the liver in sickle cell disease.","volume":"119","author":"Charlotte","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R23-5-20250124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"Algorithm for the grading of activity in chronic hepatitis C.","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R25-5-20250124","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00277-005-1015-7","article-title":"Deferiprone as an oral iron chelator in sickle cell disease.","volume":"84","author":"Voskaridou","year":"2005","journal-title":"Ann Hematol"},{"key":"R26-5-20250124","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).","volume":"115","author":"Voskaridou","year":"2010","journal-title":"Blood"},{"key":"R27-5-20250124","first-page":"1076","article-title":"Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.","volume":"91","author":"Little","year":"2006","journal-title":"Haematologica"},{"key":"R28-5-20250124","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"R29-5-20250124","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jcp.44.6.459","article-title":"Patterns of mortality in sickle cell disease in the United Kingdom.","volume":"44","author":"Gray","year":"1991","journal-title":"J Clin Pathol"},{"key":"R30-5-20250124","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death.","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"R31-5-20250124","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004836-199404000-00006","article-title":"Hepatitis C in sickle cell anemia.","volume":"18","author":"DeVault","year":"1994","journal-title":"J Clin Gastroenterol"},{"key":"R32-5-20250124","first-page":"1204","article-title":"Chronic hepatitis C in patients with sickle cell disease.","volume":"91","author":"Hasan","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R33-5-20250124","first-page":"1367","article-title":"Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.","volume":"91","author":"Ikura","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R34-5-20250124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0168-8278(98)80308-5","article-title":"A pilot randomised, controlled trial of the effect of iron depletion on long term response to alpha-interferon in patients with chronic hepatitis C.","volume":"28","author":"Fong","year":"1998","journal-title":"J Hepatol"},{"key":"R35-5-20250124","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/lt.21635","article-title":"Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.","volume":"14","author":"Roche","year":"2008","journal-title":"Liver Transpl"},{"key":"R36-5-20250124","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.","volume":"132","author":"Carrion","year":"2007","journal-title":"Gastroenterology"},{"key":"R37-5-20250124","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-6143.2006.01619.x","article-title":"Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurrent hepatitis C virus infection post-transplantation.","volume":"7","author":"Bizollon","year":"2007","journal-title":"Am J Transplant"},{"key":"R38-5-20250124","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/MEG.0b013e3283097699","article-title":"Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.","volume":"21","author":"Ancel","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R39-5-20250124","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-133-9-200011070-00033","article-title":"Successful treatment of hepatitis C in sickle-cell disease.","volume":"133","author":"Swaim","year":"2000","journal-title":"Ann Intern Med"},{"key":"R40-5-20250124","first-page":"712","article-title":"Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease.","volume":"30","author":"Ayyub","year":"2009","journal-title":"Saudi Med J"},{"key":"R41-5-20250124","first-page":"S30","article-title":"Incidence, timing, and risk factors for acute and chronic rejection.","volume":"5","author":"Neuberger","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R42-5-20250124","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jamcollsurg.2007.12.019","article-title":"Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients.","volume":"206","author":"Hong","year":"2008","journal-title":"J Am Coll Surg"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22257","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201104000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:05:41Z","timestamp":1737738341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201104000-00005"}},"subtitle":["Challenging but feasible"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22257","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}